Two quite different influenza vaccines are now licensed foruse in the United States a trivalent inactivated influenzavaccine that is administered intramuscularly and a live attenuatedinfluenza vaccine that is administered by means of a nasal spray.The trivalent inactivated vaccine was first licensed for usein military populations during the 1940s. Recommendations forits use have expanded over the years to include groups at highrisk for complications from influenza infection and their closecontacts, including health care personnel, and recently alsoto include young children from 6 to 59 months of age and householdcontacts and . . . [Full Text of this Article]
Source Information
From the Influenza Division, Centers for Disease Control and Prevention, Atlanta.
This article has been cited by other articles:
Baskin, C. R., Bielefeldt-Ohmann, H., Garcia-Sastre, A., Tumpey, T. M., Van Hoeven, N., Carter, V. S., Thomas, M. J., Proll, S., Solorzano, A., Billharz, R., Fornek, J. L., Thomas, S., Chen, C.-H., Clark, E. A., Murali-Krishna, K., Katze, M. G.
(2007). Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus. J. Virol.
81: 11817-11827
[Abstract][Full Text]
(2007). Attenuated vs. Inactivated Flu Vaccine in Children: Benefits and Adverse Effects. JWatch Infect. Diseases
2007: 1-1
[Full Text]
(2007). Flu Shots or Intranasal Flu Vaccine for Children?. JWatch Pediatrics
2007: 1-1
[Full Text]